Literature DB >> 2917068

Prognostic factors in patients dying of well-differentiated thyroid cancer.

S Beenken1, O Guillamondegui, R Shallenberger, C Knapp, D Ritter, H Goepfert.   

Abstract

While some well-differentiated cancers of the thyroid gland are unusually aggressive, most have a more benign clinical behavior, making it difficult to evaluate factors possibly influencing patient survival such as initial surgical treatment. By studying 135 patients who received their initial surgical therapy at our institution, we have defined the prognostically significant factors. Sixteen patients (11.9%) died of disease during a ten- to 20-year follow-up period. Significant factors associated with death from disease were aged 40 years or older, primary lesion size of 2.5 cm or greater, presence of invasive characteristics, and presence of distant metastases. We recommend total thyroidectomy and postoperative sodium iodide I 131 therapy in patients 40 years of age or older, while suggesting a less aggressive approach may be appropriate in the younger patients.

Entities:  

Mesh:

Year:  1989        PMID: 2917068     DOI: 10.1001/archotol.1989.01860270068017

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  3 in total

Review 1.  Thyroid cancer in children and adolescents.

Authors:  Furio Pacini
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

2.  Characteristics and prognostic factors in patients with differentiated thyroid cancer who underwent a total or subtotal thyroidectomy: surgical approach for high-risk patients.

Authors:  T Kobayashi; H Asakawa; Y Komoike; Y Tamaki; M Monden
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

3.  Prognostic factors in patients with multiple recurrences of well-differentiated thyroid carcinoma.

Authors:  Theresa Holler; Jenna Theriault; Richard J Payne; Jonathan Clark; Spiro Eski; Jeremy L Freeman
Journal:  J Oncol       Date:  2009-10-15       Impact factor: 4.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.